A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal muscle atrophy (SMA), an inherited neuromuscular disease.
In a small human trial in SMA patients neurostimulation sessions improved motoneuron function, reduced fatigue, and improved leg muscle strength and walking.
A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal ...
GBS is a rare disorder where the immune system attacks the peripheral nervous system which carries signals from the brain and spinal cord to the rest of the body, causing muscle weakness and paralysis ...
The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...
Researchers are paving the way for the design of bionic limbs that feel natural to users. They demonstrate the connection ...
The nervous system is a complex network of neurons and cells that carry messages to and from the brain and spinal cord to various ... linked to persistent severe peripheral nerve pain (neuropathy ...
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...
Under this condition, which can result from traumatic injuries, infections, metabolic problems, or could be inherited due to ...
Guillain-Barre Syndrome (GBS) is a rare neurological disorder characterized by sudden numbness, breathing and swallowing problems, pain, muscle weakness.
NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing neurorestorative ...
The nervous system is a central component of the human body, but most people don't spend much time thinking about it.